Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women

被引:61
作者
Rodríguez, JP [1 ]
Ríos, S [1 ]
Fernández, M [1 ]
Santibañez, JF [1 ]
机构
[1] Univ Chile, INTA, Lab Biol Celular, Santiago, Chile
关键词
osteogenesis; osteoporosis; mesenchymal stem cells; mitogen-activated protein kinase; extracellular signal-regulated protein kinase; p-ERK;
D O I
10.1002/jcb.20119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteoblasts, the cells responsible for bone formation, derive from mesenchymal stem cells (MSCs) in bone marrow. To acquire a new cell phenotype, uncommitted MSCs must undergo several proliferation and differentiation changes. Although, it is known that extracellular signal-regulated protein kinases (ERKs) mitogen-activated protein (MAP) kinase pathway signaling is involved in the proliferation and differentiation processes, the role of ERKs in osteogenic differentiation it is controversial, at present. In addition, the function that ERK could play in MSCs derived from osteoporotic patients it is not well documented. In this study, we analyze whether previously observed differences in the dynamic response of MSCs from normal and osteoporotic postmenopausal women can be explained by changes in the activation of this signal transduction pathway. Levels of ERK phosphorylation and their correlation with osteogenic differentiation were evaluated in cultures of MSCs derived from osteoporotic postmenopausal women and "healthy" controls. The results show that, under basal conditions, MSCs derived from osteoporotic donors show a level of ERK phosphorylation 2.5 times higher than MSCs derived from control donors. The addition of the osteogenic stimulus only slightly increases the p-ERK level in cells derived from osteoporotic donors, and is higher in cells derived from control women. Important differences in the ability of PD98059 to inhibit phosphorylation of ERK in both types of cells were also observed, as well as the effect that this inhibition produced on calcium deposition. We conclude that the MAP kinase pathway signaling is differentially activated in MSCs derived from osteoporotic postmenopausal women. The high p-ERK levels in MSC derived from osteoporotic donors could determine the unresponsiveness of these cells to the osteogenic differentiation stimulus. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:745 / 754
页数:10
相关论文
共 33 条
[1]   Diseases of bone and the stromal cell lineage [J].
Bianco, P ;
Robey, PG .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (03) :336-341
[2]   MESENCHYMAL STEM-CELLS [J].
CAPLAN, AI .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) :641-650
[3]   A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse [J].
Dennis, JE ;
Merriam, A ;
Awadallah, A ;
Yoo, JU ;
Johnstone, B ;
Caplan, AI .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (05) :700-709
[4]   Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2Cl2 cells [J].
Gallea, S ;
Lallemand, F ;
Atfi, A ;
Rawadi, G ;
Ramez, V ;
Spinella-Jaegle, S ;
Kawai, S ;
Faucheu, C ;
Huet, L ;
Baron, R ;
Roman-Roman, S .
BONE, 2001, 28 (05) :491-498
[5]   The function of adipocytes in the bone marrow stroma: An update [J].
Gimble, JM ;
Robinson, CE ;
Wu, X ;
Kelly, KA .
BONE, 1996, 19 (05) :421-428
[6]   CHARACTERIZATION OF CELLS WITH OSTEOGENIC POTENTIAL FROM HUMAN MARROW [J].
HAYNESWORTH, SE ;
GOSHIMA, J ;
GOLDBERG, VM ;
CAPLAN, AI .
BONE, 1992, 13 (01) :81-88
[7]   Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix [J].
Higuchi, C ;
Myoui, A ;
Hashimoto, N ;
Kuriyama, K ;
Yoshioka, K ;
Yoshikawa, H ;
Itoh, K .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (10) :1785-1794
[8]   CYTOKINES AND ESTROGEN IN BONE - ANTI-OSTEOPOROTIC EFFECTS [J].
HOROWITZ, MC .
SCIENCE, 1993, 260 (5108) :626-627
[9]   Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation [J].
Hu, YY ;
Chan, E ;
Wang, SX ;
Li, BJ .
ENDOCRINOLOGY, 2003, 144 (05) :2068-2074
[10]  
Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO